Abstract
Fibrin Heterologous Sealant (FHS), developed by a Brazilian public university, is a low cost-effective, coagulant, adhesive, sealant biopolymer with properties already tested in the Phase I/II clinical trial in chronic venous ulcers. Recently we also discovered its capacity for cellular scaffold and drug delivery system. On the other hand, regenerative stem cell-based therapies have been …
